Texture analysis of the apparent diffusion coefficient focused on contrast-enhancing lesions in predicting survival for Bevacizumab-treated patients with recurrent Glioblastoma

Abstract

The authors analyzed the usefulness of Magnetic resonance texture analysis (MRTA) in predicting outcomes of patients with recurrent glioblastoma treated with bevacizumab. MRTA is a radiomics approach that aims to quantify macroscopic tissue heterogeneity by analyzing various parameters based on the distribution of pixel values. MRTA have been associated with glioma grade, molecular status, treatment response, and survival. In this study, they suggested that MRTA helps predict survival in patients with recurrent glioblastoma treated with bevacizumab